Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples

D Angeloni1, A Danilkovitch-Miagkova, S V Ivanov

  • 1Laboratory of Immunobiology, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland. andreazzolid@mail.ncifcrf.gov

Insights

Researchers investigated the human RON gene

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The human RON gene (MST1R) is located in a chromosomal region frequently altered in lung cancer.
  • RON encodes a receptor tyrosine kinase (RTK) related to MET, a gene implicated in cancer development.
  • Understanding RON's role may offer insights into lung cancer pathogenesis.

Purpose of the Study:

  • To investigate the potential involvement of the RON gene in lung cancer development and progression.
  • To characterize the exon-intron structure of the human RON gene.
  • To develop mutation analysis tools for the RON gene.

Main Methods:

  • Determined the exon-intron structure of the RON gene via DNA sequencing and PCR.
  • Developed intron-anchored primers for mutation analysis using single-strand conformation polymorphism (SSCP).
  • Analyzed RON in lung cancer cell lines and patient samples (small and non-small cell lung cancer).

Main Results:

  • Characterized twenty coding exons of the RON gene, noting their small average size.
  • Detected RON expression in lung cancer cell lines.
  • Identified a specific mutation (T915C: L296P) in an adenocarcinoma specimen and found several single nucleotide polymorphisms (SNPs).

Conclusions:

  • The study characterized the RON gene structure and developed primers for mutation analysis.
  • A mutation and SNPs in RON were identified in lung cancer samples, suggesting its potential role.
  • The developed primer panel is valuable for future RON gene mutation studies in various human tumors.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...